ToolGen Incorporated

As of June 30, 2026, ToolGen Incorporated carries a market capitalization of 335.07B, placing it among publicly traded companies globally. Its enterprise value stands at 316.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, ToolGen Incorporated has 9.15M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 172.95, and the price-to-book ratio stands at 7.21.

These figures are as of June 30, 2026. The EV/Sales ratio of 165.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 316.18B versus a market cap of 335.07B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, ToolGen Incorporated maintains a current ratio of 6.10, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.36, indicating conservative leverage, while an interest coverage ratio of -49.11 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, ToolGen Incorporated posted a negative return on equity (ROE) of -77.36, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -62.86, reflecting losses generated across the asset base. The company generates approximately 27.32M in revenue per employee across its workforce of 70.00, a quick read on workforce productivity versus industry peers.

As of the close on October 23, 2026, ToolGen Incorporated's stock has declined approximately 49.07% over the past 52 weeks. The 50-day moving average sits at 34,132.00, while the 200-day moving average is 51,599.51.

Over the twelve months ended June 30, 2026, ToolGen Incorporated generated 1.91B in revenue and converted that into -39.12B in net income, yielding earnings per share of -4,333.25. EBITDA reached -22.03B, while operating income came in at -23.82B.

As of June 30, 2026, ToolGen Incorporated holds 19.06B in cash and equivalents against 168.41M in total debt, resulting in a net debt position of -8.63B. Total book value stands at 46.50B, with working capital of 16.67B providing operational flexibility.

ToolGen Incorporated produced -21.76B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.11B in capital expenditures, free cash flow totaled -23.87B - equivalent to -2,644.11 per share.

Over the twelve months ended June 30, 2026, ToolGen Incorporated posted a gross margin of 92.01, reflecting its pricing power and cost economics. The operating margin of -1,245.64 and net profit margin of -2,045.48 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.22: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.12, meaning ToolGen Incorporated raised more capital through share issuance and new debt than it returned via dividends and buybacks.

ToolGen Incorporated's most recent stock split took place on August 7, 2026 with a 839:853 split ratio.

As of June 30, 2026, ToolGen Incorporated has an Altman Z-Score of 35.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.